ArticleScientific reports2026
Characterization and preliminary cytotoxic effects of pomegranate peel extract-loaded nanoparticles on HepG2 cells.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Punica granatum (pomegranate) peel is recognized for its rich phytochemical profile and traditional use in medicinal applications, making it a promising source of anticancer agents. In this study, an aqueous pomegranate peel extract (PPE) was prepared and encapsulated into chitosan nanoparticles (CSPPE) using the ionic gelation method. The resulting CSPPE nanoparticles were characterized by dynamic light scattering (DLS) and transmission electron microscopy (TEM), revealing nanoscale size distribution (Z-average 408.8 ± 98.8 nm by DLS, TEM mean 51.5 ± 12.6 nm) and good colloidal stability, with positive zeta potential (+ 15–35 mV) supporting electrostatic stabilization. Fourier-transform infrared spectroscopy (FTIR) indicated successful physical entrapment of PPE within the chitosan matrix, with characteristic functional groups preserved. The cytotoxic activity of both PPE and CSPPE was assessed against human hepatocellular carcinoma (HepG2) cells using the MTT assay. PPE showed moderate cytotoxicity only at high concentrations (IC₅₀ = 921.8 ± 18.6 µg/mL), while CSPPE induced markedly stronger, concentration-dependent cytotoxic effects across all tested doses (IC₅₀ = 12.38 ± 0.28 µg/mL PPE-equivalent), representing approximately a 75-fold increase in potency. Blank chitosan nanoparticles without PPE exhibited minimal cytotoxicity (> 90% cell viability), confirming that the observed enhancement is attributable to PPE encapsulation. Microscopic observations corroborated the dose-dependent cytotoxic effects, showing reduced cell density, loss of adhesion, and morphological changes consistent with cell death. These findings demonstrate that nanoencapsulation significantly enhances the bioactivity of pomegranate peel extract against hepatocellular carcinoma cells. While this study provides strong preliminary evidence, further in vitro mechanistic assays and in vivo investigations are warranted to elucidate the mode of cell death, assess selectivity towards cancer versus normal hepatocytes, and confirm therapeutic potential and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.